Hologic (NASDAQ:HOLX) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.55-0.57 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.58. The company issued revenue guidance of $795-810 million, compared to the consensus revenue estimate of $812.77 million.Hologic also updated its FY 2019 guidance to $2.39-2.43 EPS.
Shares of HOLX stock traded down $0.66 during trading hours on Thursday, hitting $44.35. 223,241 shares of the company were exchanged, compared to its average volume of 2,205,370. The company has a quick ratio of 0.95, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. Hologic has a 52-week low of $35.10 and a 52-week high of $45.28. The firm has a market cap of $12.84 billion, a P/E ratio of 19.90, a PEG ratio of 2.03 and a beta of 0.73.
Hologic (NASDAQ:HOLX) last issued its quarterly earnings results on Wednesday, January 30th. The medical equipment provider reported $0.58 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.01. Hologic had a negative net margin of 3.46% and a positive return on equity of 23.52%. The company had revenue of $830.70 million during the quarter, compared to analyst estimates of $823.22 million. During the same quarter last year, the business posted $0.55 EPS. Hologic’s quarterly revenue was up 5.0% compared to the same quarter last year. As a group, equities analysts expect that Hologic will post 2.4 EPS for the current year.
In other news, insider Benjamin Jordan Cohn sold 10,000 shares of the business’s stock in a transaction on Friday, November 30th. The shares were sold at an average price of $44.49, for a total transaction of $444,900.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Allison P. Bebo sold 6,500 shares of the business’s stock in a transaction on Friday, November 16th. The shares were sold at an average price of $42.00, for a total transaction of $273,000.00. The disclosure for this sale can be found here. Insiders sold a total of 36,355 shares of company stock valued at $1,584,655 over the last quarter. 0.90% of the stock is owned by company insiders.
Hologic Company Profile
Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.
Featured Article: The components of the Stochastic Momentum Index
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.